Chemical Proteomics: Drug Targets, Drug Selectivity, MoA and Resistance Dr. Guillaume Médard, Technische Universität München, speaking at Discovery Chemistry Congress 2013.
Detection of Rare Cancer Cell Phenotypes by Single Cell Analysis of Surface Proteins Rajan Kumar, Genome Data Systems, Inc., speaking at Lab-on-a-Chip World Congress 2012
The Use of -omic Technologies for Biomarker Development Michael Pfaffl, Principal Investigator, Technical University of Munich, speaking at Genomics Research Asia 2012
Bicyclic Peptides with Antibody-Like Binding Affinity and Specificity Dr Vanessa Baeriswyl, EPFL, speaking at Stem Cells & Bioprocessing Europe 2012.
Typical Phospho-form Abundance Profile of Cellular ERK Discovered by Quantitative UPLC-MS Wolf Lehmann, German Cancer Research Center, speaking at Systems Biology Europe 2012
Proteomic and Bioinformatic Approaches to the Development of Biomarker Signatures of Clinical Utility for Prostate Cancer: From Discovery to Targeted Verification Stephen Pennington, University College Dublin, speaking at Systems Biology Europe 2012
Secretome Proteomics for Tumor Biomarker Discovery Josep Villanueva, Vall d'Hebron Institute of Oncology (VHIO), speaking at Systems Biology Europe 2012
In vivo SILAC-based Proteomics Reveals Phosphoproteome Changes during Skin Carcinogenesis Sara Zanivan, Beatson Institute for Cancer Research, speaking at Systems Biology Europe 2012
Results From Serum-Tumorautoantibody Profiling of Breast, Colon, Lung and Prostate Cancers Using a 16k Protein Array for Improving Minimal Invasive Diagnostics Andreas Weinhäusel, Austrian Institute of Technology GmbH, speaking at Systems Biology Europe 2012